Table 2.
Angiographic parameters
| Variables | GSH group (n=25) |
Placebo group (n=25) |
P value |
| Ischaemia time# (min; mean±SD) | 286±88 | 270±96 | 0.85 |
| Thrombus burden ≥3, n (%) | 12 (48) | 11 (44) | 0.77 |
| Thrombus aspiration, n (%) | 13 (52) | 12 (48) | 0.87 |
| GP IIb/IIIa inhibitors, n (%) | 2 (8) | 3 (12) | 0.63 |
| MVD, n (%) | 13 (52) | 11 (44) | 0.77 |
| 2 vessels, | 8 (32) | 5 (20) | |
| 3 vessels, | 5 (20) | 6 (24) | |
| Staged PCI, n (%) | 9 (36) | 5 (20) | 0.89 |
| IRA | |||
| LAD, n (%) | 10 (40) | 9 (36) | 0.77 |
| LCx, n (%) | 5 (20) | 6 (24) | 0.73 |
| RCA, n (%) | 10 (40) | 10 (40) | 1 |
Ischaemia time was defined as the timing between symptom onset and balloon inflation.
GSH, glutathione; GP, general practitioner; IRA, infarct related coronary artery; LAD, left anterior descending coronary artery; LCx, left circumflex coronary artery; PCI, percutaneous coronary intervention; RCA, Right coronary artery.